1 research outputs found
ANMCO/ISS/AMD/ANCE/ARCA/FADOI/GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/SID/SIF/SIMEU/SIMG/SIMI/SISA Joint Consensus Document on cholesterol and cardiovascular risk: diagnostic–therapeutic pathway in Italy
- Author
- ACCORD Study Group
- Alberico Catapano
- Aldo Pietro Maggioni
- Alessandro Mugelli
- American Heart Association
- American Heart Association Strategic Planning Task Force and Statistics Committee
- Andrea Di Lenarda
- Antonio Vittorio Panno
- ASPIRE-2-PREVENT Study Group
- Attilio Maseri
- BLITZ-4 Investigators
- Canadian Institute for Health Information Partnership for Health Information Standards
- Carmine Riccio
- Cholesterol Treatment Trialists’ (CTT) Collaboration
- Claudio Cricelli
- Clinical and Laboratory Standards Institute
- Comparative effectiveness Public Advisory Council (CEPAC) and Institute for Clinical and Economic Review (ICER) Review
- Coronary Drug Project Research Group
- Damiano Parretti
- Determinazione AIFA
- Enrico Pusineri
- Enzo Bonora
- EUROASPIRE Investigators
- EUROASPIRE Study Group
- European Association for Cardiovascular Prevention and Rehabilitation (EACPR)
- European Atherosclerosis Society Consensus Panel
- European Medicines Agency
- European Medicines Agency
- European Medicines Agency
- European Society of Cardiology
- Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults
- Federazione Italiana di Cardiologia
- Federico Nardi
- Ferruccio Ceriotti
- Francesco Perticone
- Francesco Romeo
- Francesco Rossi
- Furio Colivicchi
- Gerardo Medea
- Giorgio Cantelli Forti
- Giovanni Battista Zito
- GISSI-Prevenzione Investigators (Gruppo Italiano per la Sopravvivenza nell’Infarto Miocardico)
- Giuseppe Musumeci
- Gruppo di Ricerca dell’Osservatorio Epidemiologico Cardiovascolare/Health Examination Survey
- Gualtiero Ricciardi
- Heart Protection Study Collaborative Group
- Heart Protection Study Collaborative Group
- HPS2-THRIVE Collaborative Group
- Il Progetto CUORE
- Il Sole-24 Ore. Info Data Blog
- IMPROVE-IT Investigators
- Incremental Decrease in End Points Through Aggressive Lipid Lowering (IDEAL) Study Group
- Institute for Clinical and Economic Review
- Leonardo Bolognese
- Marcello Arca
- Marcello Ciaccio
- Maria Pia Ruggieri
- Maria Stella Graziani
- Marino Scherillo
- Maurizio Averna
- Maurizio Giuseppe Abrignani
- Mauro Campanini
- Michele Massimo Gulizia
- Multiple Risk Factor Intervention Trial Research Group
- National Heart Lung, and Blood Institute
- NHS Foundation Trust
- Nicoletta Musacchio
- Nutrition Committee
- ODYSSEY LONG TERM Investigators
- Open-Label Study of Long-Term Evaluation against LDL Cholesterol (OSLER) Investigators
- Pasquale Perrone Filardi
- per ANMCO SIMG e SISA
- Phase 3 HoFH Lomitapide Study Investigators
- Pompilio Massimo Faggiano
- PREDIMED Study Investigators
- Prospective Studies Collaboration
- PROspective Study of Pravastatin in the Elderly at Risk
- Raffaele Griffo
- Rapporto ARNO
- Roberto Ferrari
- Scandinavian Simvastatin Survival Study Group
- Simona Giampaoli
- Standards SID/AMD
- The Evaluation of Bococizumab
- The Evaluation of Bococizumab
- The National Lipid Association Statin Intolerance Panel
- Treating to New Targets (TNT) Investigators
- World Health Organization
- World Health Organization
- Publication venue
- 'Oxford University Press (OUP)'
- Publication date
- Field of study
No full text
